R&D tax credit included in $700 billion bailout plan
This article was originally published in The Gray Sheet
Executive Summary
Extension of research and development tax provisions favored by the device industry is attached to the $700 billion Emergency Economic Stabilization Act of 2008, passed by the House and Senate last week and signed by President Bush Oct. 3 ("1The Gray Sheet" Dec. 10, 2007, p. 14)You may also be interested in...
R&D Tax-Credit Extension Goes Down To The Wire
Device lobbyists are joining a year-end push for an extension of a soon-to-expire tax credit for companies engaged in research and development, but opportunities are running out
FDA Commissioner Nominee Hahn Advances To Full Senate, Despite Some Dems’ Reservations
Stephen Hahn, the Trump administration’s nominee to lead the US FDA, has been approved by the Senate Health, Education, Labor and Pensions (HELP) Committee, with some “no votes” from Democratic senators in leadership positions, and is expected to be considered by the full Senate this week.
FDA Holding February Public Meeting On Using AI In Radiology
The US agency will host a two-day meeting to discuss the evolution of artificial intelligence technology used to analyze radiological images when diagnosing patients and in advising radiologists to take optimal pictures. The takeaways from the meeting will be used by the FDA to help it develop its thinking on how to regulate such technology.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Medtech Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: